resTORbio, Inc. (100)

Browse by Contract Category

Contracts

Fifth Amendment to Loan and Security Agreement, dated December 2, 2022 (Filed With SEC on December 8, 2022)
Antibody Discovery Agreement, dated as of March 23, 2021, by and between the Registrant and Twist Bioscience Corporation (Filed With SEC on November 8, 2022)
Second Amendment to Lease, dated as of June 16, 2022, between Adicet Therapeutics, Inc. as Tenant, and Westport Office Park, LLC, as Landlord (incorporated by reference to Exhibit... (Filed With SEC on August 10, 2022)
Amended and Restated 2018 Stock Option and Incentive Plan and forms of award agreements thereunder (Filed With SEC on March 15, 2022)
Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on March 15, 2022)
Amended and Restated License Agreement, dated as of May 21, 2014, by and between Technion Research and Development Foundation Ltd., acting on behalf of itself and the... (Filed With SEC on September 16, 2020)
Agreement and Plan of Merger, dated April 28, 2020, by and among resTORbio, Inc., Adicet Bio, Inc. and Project Oasis Merger Sub, Inc (Filed With SEC on April 29, 2020)
Second Amendment to Lease, dated as of June 16, 2022, between Adicet Therapeutics, Inc. as Tenant, and Westport Office Park, LLC, as Landlord (Filed With SEC on June 21, 2022)
Change Order No. 3, dated March 18, 2022, by and between Adicet Therapeutics, Inc. and CP Enterprises, Inc. d/b/a CP Construction (Filed With SEC on March 24, 2022)
Change Order No. 2, dated March 18, 2022, by and between Adicet Therapeutics, Inc. and CP Enterprises, Inc. d/b/a CP Construction (Filed With SEC on March 24, 2022)
Change Order No. 1, dated September 23, 2021, by and between Adicet Therapeutics, Inc. and CP Enterprises, Inc. d/b/a CP Construction (Filed With SEC on March 24, 2022)
Amended and Restated 2018 Employee Stock Purchase Plan (Filed With SEC on March 15, 2022)
Specimen Common Stock Certificate (Filed With SEC on March 15, 2022)
Adicet Bio, Inc. 2022 Inducement Plan and forms of award agreements thereunder (Filed With SEC on March 15, 2022)
Form of Employment Agreement (Filed With SEC on March 15, 2022)
Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 15, 2022)
Amended and Restated Senior Executive Cash Incentive Bonus Plan (Filed With SEC on March 15, 2022)
Underwriting Agreement, dated as of December 7, 2021, by and among the Company and Jefferies, LLC and Guggenheim Securities, LLC, as representatives of the several underwriters... (Filed With SEC on December 10, 2021)
Affirmation and Amendment of Guaranty, dated October 21, 2021 (Filed With SEC on October 25, 2021)
Fourth Amendment to Loan and Security Agreement, dated October 21, 2021 (Filed With SEC on October 25, 2021)
Sublease Agreement by and between Adicet Bio, Inc. and RFS Opco LLC, dated July 19, 2021 (Filed With SEC on July 26, 2021)
Second Amendment to Business Park Lease, dated October 19, 2020, by and between the Registrant and Facebook, Inc (Filed With SEC on July 1, 2021)
Third Amendment to Business Park Lease, dated June 25, 2021, by and between the Registrant and Facebook, Inc (Filed With SEC on July 1, 2021)
Standard Form of Agreement between Owner and Contractor Where the Basis for Payment is a Stipulated Sum, effective as of April 2, 2021, by and between Adicet Therapeutics, Inc.,... (Filed With SEC on April 9, 2021)
Registration Rights Agreement, dated February 12, 2021, by and among the Registrant and the Investors named therein (Filed With SEC on March 12, 2021)
Underwriting Agreement, dated as of February 10, 2021, by and among the Company and Guggenheim Securities, LLC, as representatives of the several underwriters listed on Schedule A... (Filed With SEC on February 16, 2021)
Form of Registration Rights Agreement (Filed With SEC on February 16, 2021)
Stock Purchase Agreement, dated February 12, 2021, by and among Adicet Bio, Inc. and the Investors named therein (Filed With SEC on February 16, 2021)
First Amendment to Lease, dated as of December 30, 2020, between Adicet Therapeutics, Inc. as Tenant, and Westport Office Park, LLC as Landlord (Filed With SEC on January 5, 2021)
Sales Agreement, by and among Adicet Bio, Inc., Evercore Group L.L.C. and H.C. Wainwright & Co., LLC, dated December 1, 2020 (Filed With SEC on December 1, 2020)
Employment Agreement, dated as of September 15, 2020, by and between the Company and Stewart Abbot, Ph.D (Filed With SEC on October 8, 2020)
Employment Agreement, dated as of September 15, 2020, by and between the Company and Nick Harvey (Filed With SEC on September 18, 2020)
Employment Agreement, dated as of September 15, 2020, by and between the Company and Lloyd Klickstein (Filed With SEC on September 18, 2020)
Employment Agreement, dated as of September 15, 2020, by and between the Company and Francisco Galimi (Filed With SEC on September 18, 2020)
Employment Agreement, dated as of September 15, 2020, by and between the Company and Carrie Krehlik (Filed With SEC on September 18, 2020)
Employment Agreement, dated as of September 15, 2020, by and between the Company and Chen Schor (Filed With SEC on September 18, 2020)
Loan and Security Agreement, dated as of April 28, 2020, between Adicet Therapeutics, Inc. and Pacific Western Bank (Filed With SEC on September 16, 2020)
Amendment No. 1 to the Adicet Therapeutics, Inc. Share Option Plan (2014) (Filed With SEC on September 16, 2020)
Form of Adicet Therapeutics, Inc. Share Option Plan (2014) Stock Option Award Notice (Filed With SEC on September 16, 2020)
Lease Agreement, dated as of October 31, 2018, by and between Westport Office Park, LLC and Adicet Therapeutics, Inc (Filed With SEC on September 16, 2020)
Business Park Lease, dated as of September 30, 2015, by and between Adicet Therapeutics, Inc. and David D. Bohannon Organization (Filed With SEC on September 16, 2020)
Amendment to Business Park Lease, dated as of September 2019, between Adicet Therapeutics, Inc. and David D. Bohannon Organization (Filed With SEC on September 16, 2020)
Amendment No. 1 to License and Collaboration Agreement, dated as of April 24, 2019, by and between Adicet Therapeutics, Inc. and Regeneron Pharmaceuticals, Inc (Filed With SEC on September 16, 2020)
Amendment No. 1 to Amended and Restated License Agreement, dated as of June 30, 2015, by and between Technion Research and Development Foundation Ltd., acting on behalf of itself... (Filed With SEC on September 16, 2020)
Amendment No. 2 to Amended and Restated License Agreement, dated as of January 13, 2016, by and between Technion Research and Development Foundation Ltd., Applied Immune... (Filed With SEC on September 16, 2020)
License and Collaboration Agreement, dated as of July 29, 2016, by and between Adicet Therapeutics, Inc. and Regeneron Pharmaceuticals, Inc (Filed With SEC on September 16, 2020)
Form of Adicet Therapeutics, Inc. 2015 Stock Incentive Plan Restricted Stock Purchase Award Agreement (Filed With SEC on September 16, 2020)
Amendment No. 1 to Loan and Security Agreement, dated as of July 8, 2020, between Adicet Therapeutics, Inc. and Pacific Western Bank (Filed With SEC on September 16, 2020)
First Amendment to the Adicet Bio, Inc. 2018 Stock Option and Incentive Plan (Filed With SEC on September 16, 2020)
Adicet Therapeutics, Inc. Share Option Plan (2014) (Filed With SEC on September 16, 2020)
Form of Adicet Therapeutics, Inc. 2015 Stock Incentive Plan Stock Option Agreement (Israel - 102) (Filed With SEC on September 16, 2020)
Escrow Agreement, dated as of September 15, 2020 by and among resTORbio, Inc. and the investors listed on the Schedule of Investors attached thereto (Filed With SEC on September 16, 2020)
Unconditional Secured Guaranty, dated September 15, 2020 (Filed With SEC on September 16, 2020)
Form of Adicet Therapeutics, Inc. 2015 Stock Incentive Plan Stock Option Agreement (Israel 3(i)) (Filed With SEC on September 16, 2020)
Contingent Value Rights Agreement, dated as of September 15, 2020 by and among resTORbio, Inc., Computershare Inc. and Computershare Trust Company, N.A (Filed With SEC on September 16, 2020)
Second Amendment to Loan and Security Agreement, dated as of September 14, 2020, by and between Pacific West Bank and Adicet Therapeutics, Inc (Filed With SEC on September 16, 2020)
Third Amendment to Loan and Security Agreement, dated as of September 15, 2020, by and between Pacific West Bank and Adicet Therapeutics, Inc (Filed With SEC on September 16, 2020)
Warrant to Purchase Common Stock issued to PacWest Bancorp, dated September 15, 2020 (Filed With SEC on September 16, 2020)
Form of Warrant to Purchase Common Stock issued to Beech Hill Securities, dated September 15, 2020 (Filed With SEC on September 16, 2020)
Transition Agreement, dated April 28, 2020, as amended, by and between Adicet Therapeutics, Inc. and Anil Singhal (Filed With SEC on September 16, 2020)
Independent Contractor Services Agreement, dated as of April 28, 2020, by and between Adicet Therapeutics, Inc. and Anil Singhal (Filed With SEC on September 16, 2020)
Adicet Therapeutics, Inc. 2015 Stock Incentive Plan (Filed With SEC on September 16, 2020)
Adicet 2015 Plan - Israeli Sub Plan (Filed With SEC on September 16, 2020)
Form of Adicet Therapeutics, Inc. 2015 Stock Incentive Plan Stock Option Agreement (Immediately Exercisable) (Filed With SEC on September 16, 2020)
Form of Adicet Therapeutics, Inc. 2015 Stock Incentive Plan Stock Option Agreement (Non-Immediately Exercisable) (Filed With SEC on September 16, 2020)
Amendment to Stewart Abbots Employment Offer Letter, dated as of June 18, 2020, between Adicet Bio, Inc. and Stewart Abbot, Ph.D (Filed With SEC on June 23, 2020)
Form of Adicet Bio, Inc. 2015 Stock Incentive Plan Stock Option Agreement (Israel 3(i)) (Filed With SEC on June 23, 2020)
Form of Adicet Bio, Inc. 2015 Stock Incentive Plan Stock Option Agreement (Non-Immediately Exercisable) (Filed With SEC on June 23, 2020)
Form of Adicet Bio, Inc. 2015 Stock Incentive Plan Stock Option Agreement (Immediately Exercisable) (Filed With SEC on June 23, 2020)
Adicet 2015 Plan Israeli Sub Plan (Filed With SEC on June 23, 2020)
Adicet Bio, Inc. 2015 Stock Incentive Plan (Filed With SEC on June 23, 2020)
Business Park Lease, dated as of September 30, 2015, by and between Adicet Bio, Inc. and David D. Bohannon Organization (Filed With SEC on June 23, 2020)
Employment Offer Letter, dated as of May 17, 2018, between the Adicet Bio, Inc. and Stewart E. Abbot (Filed With SEC on June 23, 2020)
Employment Offer Letter, dated as of November 1, 2017, between Adicet Bio, Inc. and Carrie A. Krehlik (Filed With SEC on June 23, 2020)
Amendment to Francesco Galimis Employment Offer Letter, dated as of April 25, 2020, between Adicet Bio, Inc. and Francesco Galimi, M.D. Ph.D (Filed With SEC on June 23, 2020)
Employment Offer Letter, dated as of September 4, 2019, between Adicet Bio, Inc. and Francesco Galimi, M.D. Ph.D (Filed With SEC on June 23, 2020)
Independent Contractor Services Agreement, dated as of April 28, 2020, by and between Adicet Bio, Inc. and Anil Singhal (Filed With SEC on June 23, 2020)
Transition Agreement, dated April 28, 2020, as amended, by and between Adicet Bio, Inc. and Anil Singhal (Filed With SEC on June 23, 2020)
Form of Adicet Bio, Inc. 2015 Stock Incentive Plan Restricted Stock Purchase Award Agreement (Filed With SEC on June 23, 2020)
Form of Adicet Bio, Inc. 2015 Stock Incentive Plan Stock Option Agreement (Israel 102) (Filed With SEC on June 23, 2020)
Loan and Security Agreement, dated as of April 28, 2020, between Adicet Bio, Inc. and Pacific Western Bank (Filed With SEC on June 23, 2020)
Adicet Bio, Inc. Share Option Plan (2014) (Filed With SEC on June 23, 2020)
Amendment No. 1 to the Adicet Bio, Inc. Share Option Plan (2014) (Filed With SEC on June 23, 2020)
Form of Adicet Bio, Inc. Director and Officer Indemnification Agreement (Filed With SEC on June 23, 2020)
Amendment No. 1 to License and Collaboration Agreement, dated as of April 24, 2019, by and between Adicet Bio, Inc. and Regeneron Pharmaceuticals, Inc (Filed With SEC on June 23, 2020)
License and Collaboration Agreement, dated as of July 29, 2016, by and between Adicet Bio, Inc. and Regeneron Pharmaceuticals, Inc (Filed With SEC on June 23, 2020)
Amendment No. 2 to Amended and Restated License Agreement, dated as of January 13, 2016, by and between Technion Research and Development Foundation Ltd., Applied Immune... (Filed With SEC on June 23, 2020)
Amendment No. 1 to Amended and Restated License Agreement, dated as of June 30, 2015, by and between Technion Research and Development Foundation Ltd., acting on behalf of itself... (Filed With SEC on June 23, 2020)
Amended and Restated License Agreement, dated as of May 21, 2014, by and between Technion Research and Development Foundation Ltd., acting on behalf of itself and the... (Filed With SEC on June 23, 2020)
Form of Warrant to Purchase Stock issued to Beech Hill Securities, Inc (Filed With SEC on June 23, 2020)
Warrant to Purchase Stock, dated as of April 28, 2020, issued to Pacific Western Bank (Filed With SEC on June 23, 2020)
Amendment to Business Park Lease, dated as of September 2019, between Adicet Bio, Inc. and David D. Bohannon Organization (Filed With SEC on June 23, 2020)
Lease Agreement, dated as of October 31, 2018, by and between Westport Office Park, LLC and Adicet Bio, Inc (Filed With SEC on June 23, 2020)
Form of Adicet Bio, Inc. Share Option Plan (2014) Stock Option Award Notice (Filed With SEC on June 23, 2020)
Description of Securities (Filed With SEC on March 12, 2020)
Amendment No. 2 to License Agreement, dated August 20, 2019, by and between the Registrant and Novartis International Pharmaceutical Ltd (Filed With SEC on November 5, 2019)
Employment Agreement, dated as of May 8, 2019, between the Company and Lloyd Klickstein (Filed With SEC on August 14, 2019)
Second Amendment to Offer Letter, effective as of March 1, 2019, between the Company and Joan Mannick (Filed With SEC on May 15, 2019)
First Amendment to Office Lease, dated as of April 1, 2019, by and between the Company and 500 Boylston and 222 Berkeley Owner (DE) LLC (Filed With SEC on May 15, 2019)
Underwriting Agreement, dated as of March 19, 2019, by and among the Company and Merrill Lynch, Pierce, Fenner & Smith Incorporated and SVB Leerink LLC, as representatives of the... (Filed With SEC on March 21, 2019)